SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.156
AS - Asia 19.926
EU - Europa 13.803
SA - Sud America 3.572
AF - Africa 500
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 68.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.319
SG - Singapore 8.013
FI - Finlandia 4.767
CN - Cina 4.312
BR - Brasile 2.783
VN - Vietnam 2.313
IT - Italia 2.130
DE - Germania 1.979
HK - Hong Kong 1.675
GB - Regno Unito 947
FR - Francia 762
UA - Ucraina 731
TR - Turchia 642
JP - Giappone 624
IN - India 528
PL - Polonia 497
RU - Federazione Russa 450
ID - Indonesia 405
SE - Svezia 375
CA - Canada 366
MX - Messico 359
BD - Bangladesh 307
AR - Argentina 268
NL - Olanda 268
ZA - Sudafrica 188
IQ - Iraq 182
ES - Italia 179
CO - Colombia 133
PK - Pakistan 131
AT - Austria 130
EC - Ecuador 126
BE - Belgio 97
UZ - Uzbekistan 78
LT - Lituania 77
VE - Venezuela 77
SA - Arabia Saudita 76
PH - Filippine 74
MY - Malesia 67
KR - Corea 66
AU - Australia 63
IE - Irlanda 60
MA - Marocco 58
CH - Svizzera 53
CZ - Repubblica Ceca 53
CL - Cile 50
EG - Egitto 48
AE - Emirati Arabi Uniti 46
PY - Paraguay 44
TN - Tunisia 43
JO - Giordania 41
KE - Kenya 40
PE - Perù 38
NP - Nepal 37
IR - Iran 33
AL - Albania 32
UY - Uruguay 32
TH - Thailandia 29
DZ - Algeria 26
LB - Libano 24
KZ - Kazakistan 23
JM - Giamaica 22
IL - Israele 21
PT - Portogallo 21
TW - Taiwan 21
AZ - Azerbaigian 20
DK - Danimarca 20
DO - Repubblica Dominicana 20
KG - Kirghizistan 20
OM - Oman 19
SN - Senegal 19
ET - Etiopia 18
HR - Croazia 18
RO - Romania 17
PS - Palestinian Territory 16
RS - Serbia 15
CR - Costa Rica 14
PA - Panama 14
BG - Bulgaria 13
CY - Cipro 13
SI - Slovenia 13
HU - Ungheria 12
NI - Nicaragua 11
BO - Bolivia 10
BH - Bahrain 9
GE - Georgia 9
GR - Grecia 9
LV - Lettonia 9
MD - Moldavia 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
CI - Costa d'Avorio 8
NO - Norvegia 8
XK - ???statistics.table.value.countryCode.XK??? 8
BY - Bielorussia 7
GY - Guiana 7
HN - Honduras 7
KW - Kuwait 7
QA - Qatar 7
EE - Estonia 6
LI - Liechtenstein 6
Totale 67.895
Salva come PNG Salva come JPEG
Città #
Singapore 4.907
Ashburn 4.489
Helsinki 4.366
Fairfield 2.306
San Jose 2.141
Woodbridge 1.817
Hong Kong 1.632
Santa Clara 1.433
Beijing 1.354
Dallas 1.326
Houston 1.233
Chandler 1.034
Munich 1.029
Seattle 980
Wilmington 853
Ann Arbor 809
Cambridge 767
Jacksonville 764
Ho Chi Minh City 762
Los Angeles 645
New York 598
Tokyo 591
Hanoi 515
Warsaw 468
Lauterbourg 413
Council Bluffs 411
Ferrara 366
Izmir 344
Princeton 326
São Paulo 311
Jakarta 296
Shanghai 283
Nanjing 271
Milan 256
San Diego 212
London 207
Mexico City 206
Orem 203
Chicago 188
Turku 187
Frankfurt am Main 158
Bologna 149
Boardman 145
Montreal 134
Chennai 131
Buffalo 127
Brooklyn 121
Hefei 121
Denver 119
Nuremberg 115
Atlanta 109
Rio de Janeiro 109
Da Nang 104
Amsterdam 102
Haiphong 102
Toronto 101
Rome 96
Stockholm 96
Brussels 95
Johannesburg 94
Moscow 94
Boston 93
Phoenix 93
Tianjin 87
San Francisco 84
Poplar 81
Bremen 80
Manchester 80
Shenyang 78
The Dalles 78
Falkenstein 73
Mumbai 72
Nanchang 72
Tashkent 69
Washington 67
Baghdad 64
Lappeenranta 64
Redwood City 64
Falls Church 63
Ankara 58
Jiaxing 55
Salt Lake City 55
Belo Horizonte 54
Guangzhou 54
Paris 54
Dhaka 52
Dublin 52
Columbus 51
Quito 50
Biên Hòa 48
Medellín 47
Changsha 46
Mountain View 44
Brasília 43
New Delhi 43
Shenzhen 43
Vienna 42
Hebei 40
Hải Dương 40
Amman 39
Totale 46.093
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 2.853
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.050
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 421
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 414
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 379
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 364
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 362
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 353
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 331
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 322
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 314
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 301
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 293
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 282
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 276
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 276
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 271
Poor response to clopidogrel: current and future options for its management 269
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 262
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 260
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 258
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 258
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 253
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 246
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 245
Characterization of Dermal Stem Cells of Diabetic Patients 245
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 244
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 244
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 243
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 241
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 238
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 236
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 236
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 234
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 233
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 231
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 228
Mechanistic role of mPTP in ischemia-reperfusion injury 227
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 226
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI 225
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 224
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 224
Reperfusion Damage - A Story of Success, Failure, and Hope 220
The Mitochondrial Permeability Transition Pore 219
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 216
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 216
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 216
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 216
A serum proteome signature to predict mortality in severe COVID-19 patients 213
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 212
BRS implantation in long lesions requiring device overlapping: Myth or reality? 210
Can we improve myocardial protection during ischaemic injury? 210
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 209
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 209
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 208
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 208
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 205
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 204
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 203
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 201
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 201
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 201
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 200
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 199
Fractional flow reserve: Current applications and overview of the available data 199
Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions 199
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 198
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 197
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 196
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 195
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 194
Notch Signaling Regulates Immune Responses in Atherosclerosis 194
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 193
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 193
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 192
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 191
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 191
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 189
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 188
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 187
The Use of Multimodality Imaging for the Diagnosis of Myocardial Outpouchings and Invaginations: A Systematic Review 186
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 186
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 186
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 185
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease 185
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 185
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 184
Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trial 183
The in vitro effects of verbascoside on human platelet aggregation 183
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 183
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 182
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 181
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. 180
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 180
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 179
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 179
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy 179
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 178
Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers 177
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial 177
Totale 27.222
Salva come PNG Salva come JPEG
Categoria #
all - tutte 309.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.024
Totale 311.260
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.329 0 0 0 0 0 0 0 0 0 541 536 252
2021/20223.161 274 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/202512.666 313 330 920 586 1.425 1.211 806 708 2.320 1.302 1.514 1.231
2025/202634.574 2.969 1.574 3.299 3.858 4.751 2.088 3.630 1.945 7.207 3.253 0 0
Totale 69.316